Table 2.
Post-vaccination adverse events in patients group
| ADR | AIRD (n = 513) | Non-AIRD (n = 211) | P value (exact test) |
|---|---|---|---|
| Fatigue | 92 (17.93%) | 36 (17.06%) | 0.831 |
| Fever | 94 (18.32%) | 42 (19.90%) | 0.675 |
| Myalgia | 49 (9.55%) | 26 (12.32%) | 0.284 |
| Headache | 71 (13.84%) | 24 (11.37%) | 0.399 |
| New/increased joint pains | 14 (2.72%) | 4 (1.89%) | 0.609 |
| Diarrhea | 12 (2.33%) | 3 (1.42%) | 0.572 |
| Chills | 14 (2.72%) | 4 (1.89%) | 0.609 |
| Pain in injection site | 128 (24.95%) | 51 (24.17%) | 0.850 |
| No ADR | 207 (40.35%) | 81 (38.38%) | 0.676 |
ADR adverse drug reaction, AIRD autoimmune rheumatic disease